Use of circulating tumor DNA to guide treatment of primary central nervous system lymphoma: a case report
Neurooncol Adv
.
2021 Sep 25;3(1):vdab143.
doi: 10.1093/noajnl/vdab143.
eCollection 2021 Jan-Dec.
Authors
Ka-Wai Grace Ho
1
2
,
Tejus Bale
3
,
Christian Grommes
1
,
Ankush Bhatia
1
4
,
Rachna Malani
1
Affiliations
1
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
2
Department of Neurology, MedStar Georgetown University Hospital, Washington, District of Columbia, USA.
3
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
4
Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
PMID:
34729485
PMCID:
PMC8557694
DOI:
10.1093/noajnl/vdab143
No abstract available
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States